Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Share Issue/Capital Change 2026

Apr 10, 2026

3535_dva_2026-04-10_5c289f1e-c2a5-405e-99fa-7bda44f15453.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

abt
AQUA BIO TECHNOLOGY ASA
Press Release
10 April 2026 11:40:00 CEST

Aqua Bio Technology ASA: Share capital increase registered

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN

Reference is made to the stock exchange announcement by Aqua Bio Technology ASA ("ABTEC" or the "Company") on 23 March 2026 regarding the final result of a subsequent offering of up to 800,000 new shares (the "Offer Shares") in the Company (the "Subsequent Offering"). Following the expiry of the subscription period in the Subsequent Offering, the Board of Directors resolved to allocate a total of 388,240 Offer Shares and to increase the Company's share capital with NOK 1,941,200 through the issuance of 388,240 Offer Shares, each with a par value of NOK 5.00.

The share capital increase pertaining to the Subsequent Offering has now been registered with the Norwegian Register of Business Enterprises. The new share capital is NOK 78,080,875 divided by 15,616,175 shares, each with a par value of NOK 5.00. The Offer Shares are expected to be delivered to the VPS accounts of the subscribers today, and expected to be tradeable on 13 April 2026

Contacts

Kristian Flaten
CEO & CFO
Aqua Bio Technology ASA
Phone: +47 9509 2322
Email: [email protected]

About Us

Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in skincare and nonfood. The group has distribution towards B2C and B2B, and offers freight, customs, and logistics services. The group also develops sustainable biotechnology for use in skincare products. Aqua Bio Technology is listed on Euronext Expand Oslo.

This notice is published by Kristian Flaten on the listed date and time.

This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-04-10 11:40 CEST.

Aqua Bio Technology • Fornebuveien 37 • N-1366 Lysaker